Ignite Creation Date:
2025-12-24 @ 5:56 PM
Ignite Modification Date:
2026-02-28 @ 6:32 PM
Study NCT ID:
NCT03737968
Status:
UNKNOWN
Last Update Posted:
2023-03-21
First Post:
2018-11-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Window of Opportunity Trial of Durvalumab (MEDI4736) or Durvalumab/Tremelimumab as Neoadjuvant Chemotherapy to Identify Immune Dynamics in Surgically Resectable Head and Neck Cancer Patients.
Sponsor:
Yonsei University
Organization:
Conditions & Keywords Data
Conditions: